Huntleigh Advisors, Inc.

Position in DHR — Danaher Corp /De/

CIK 1367653 ST. LOUIS, MO

Position in DHR

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$2,642,719

+$34,392 QoQ

Shares Held

13,874

+0.9% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.44%

of 13F equity value

Holder Rank

#797

of 2,094 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Huntleigh Advisors, Inc. holds $7,935,528 across 5 Diagnostics & Research names. DHR ranks #2 (33.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NTRA	Natera, Inc.	12,210	$3,314,404
2	DHR	Danaher Corp /De/ This page	13,874	$2,642,719
3	VCYT	Veracyte, Inc.	25,918	$1,522,164
4	GH	Guardant Health, Inc.	3,041	$456,241
5	ADPT	Adaptive Biotechnologies Corp	23,293	$0

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,642,719	13,874	+0.9%	Shares	Sole	2026-08-04
2026-03-31	$2,608,327	13,757	+6.3%	Shares	Sole	2026-04-21
2025-12-31	$2,961,538	12,937	+2.6%	Shares	Sole	2026-01-29
2025-09-30	$2,500,058	12,610	+2.4%	Shares	Sole	2025-10-30
2025-06-30	$2,432,310	12,313	-0.3%	Shares	Sole	2025-07-29
2025-03-31	$2,532,980	12,356	+0.5%	Shares	Sole	2025-04-29
2024-12-31	$2,821,628	12,292	—	Shares	Sole	2025-04-29
No filing history on record for this holder in this stock.